２０２２年

2022年 業績

  1. Harada K, Hagiwara T: Gardner-Diamond syndrome complicated with chronic urticaria successfully treated with antihistamine. J Dermatol 49(2): e75-e76, 2022.
  2. Morita A, Okubo Y, Morisaki Y, Torisu-Itakura H, Umezawa Y: Ixekizumab 80 mg Every 2 Weeks Treatment Beyond Week 12 for Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis. Dermatol Ther (Heidelb) 12: 481-494, 2022.
  3. Strober B, Leman J, Mockenhaupt M, Nakano de Melo J, Nassar A, Prajapati VH, Romanelli P, Seneschal J, Tsianakas A, Wei LY, Yasuda M, Yu N, Hernandez Daly AC, Okubo Y: Unmet Educational Needs and Clinical Practice Gaps in the Management of Generalized Pustular Psoriasis: Global Perspectives from the Front Line. Dermatol Ther (Heidelb) 12: 381-393, 2022.
  4. Imafuku S, Ohata C, Okubo Y, Tobita R, Saeki H, Mabuchi T, Hashimoto Y, Murotani K, Kitabayashi H, Kanai Y: Effectiveness of brodalumab in achieving treatment satisfaction for patients with plaque psoriasis: The ProLOGUE study. J Dermatol Sci 105(3): 176-184, 2022.
  5. Okubo Y, Umezawa Y, Sakurai S, Hoshii N, Nakagawa H: Efficacy and Safety of Certolizumab Pegol in Japanese Patients with Generalized Pustular Psoriasis and Erythrodermic Psoriasis: 52-Week Results. Dermatol Ther (Heidelb) 12(6): 1397-1415, 2022.
  6. Gordon KB, Langley RG, Warren RB, Okubo Y, Stein Gold L, Merola JF, Peterson L, Wixted K, Cross N, Deherder D, Thaçi D: Bimekizumab safety in patients with moderate to severe plaque psoriasis: pooled results from phase 2 and phase 3 randomized clinical trials. JAMA Dermatol 158(7): 735-744, 2022.
  7. Okubo Y, Takahashi H, Hino R, Endo K, Kikuchi S, Ozeki Y, Nakamura T, Paris M, Abe M: Efficacy and Safety of Apremilast in the Treatment of Patients with Mild-to-Moderate Psoriasis in Japan: Results from PROMINENT, A Phase 3b, Open-Label, Single-Arm Study. Dermatol Ther (Heidelb) 12(6):1469-1480, 2022.
  8. Blauvelt A, Kimball AB, Augustin M, Okubo Y, Witte MM, Capriles CR, Sontag A, Arora V, Osuntokun O, Strober B: Efficacy and safety of mirikizumab in psoriasis: results from a 52-week, double-blind, placebo-controlled, randomized withdrawal, phase III trial (OASIS-1). Br J Dermatol 187(6):866-877, 2022.
  9. Miyagi T, Kanai Y, Murotani K, Okubo Y, Honma M, Kobayashi S, Seishima M, Mizutani Y, Kitabayashi H, Imafuku S: Itch as a critical factor in impaired health-related quality of life in patients with plaque psoriasis achieving clear or almost-clear skin: Analysis of the single-arm, open-label, multicenter, prospective ProLOGUE study. JAAD Int 8: 146-153, 2022.
  10. Tomura Y, Noto M, Komatsuda E, Nitta Y, Ishikawa N, Osada SI, Umebayashi Y, Kono M: Blaschkoid expansive eccrine nevus with a trace of hyperhidrosis confirmed by a sensitivity-reduced iodine-starch test. Eur J Dermatol 32(2): 280-281, 2022.
  11. Kato Y, Fukuhara Y, Nagatani T, Kanzaki A, Mae K, Irisawa R, Harada K, Umebayashi Y, Tsuboi R: Low-Dose MST-16/VP-16 Combination Chemotherapy in 9 Patients with Tumor Stage Mycosis Fungoides. Dermatology 238(5): 961-966, 2022.
  12. Yamada A, Kawase M, Matsumoto T, Demitsu T, Etoh T: Papular acantholytic dyskeratosis in a male patient localized to the anogenital area mimicking condyloma acuminatum. J Dermatol 49(2): e57-e58, 2022.
  13. Shimura E, Suto H, Numata T, Yamaguchi S, Harada K, Okumura K, Sudo K, Ikutani M, Nakae S: IL-25 contributes to development of chronic contact dermatitis in C57BL/6 mice, but not BALB/c mice. Biochem Biophys Res Commun 628:57-63, 2022.
  14. Nogita A, Harada K, Kawakami H, Maeda T, Saito M, Tsuboi R: Giant amoebic perianal ulcer in a HIV-positive homosexual man. J Dermatol 49(2): e73-e74, 2022.
  15. Masuda-Kuroki K, Kawakami H, Abe N, Mori M, Tobita R, Fukushi R, Hiruma J, Takeda Y, Okubo Y: Nail lesions in palmoplantar pustulosis and pustulotic arthro-osteitis impairs patients' quality of life: Suggesting new assessment tool of PPP nail lesions. J Dermatol Sci 106: 29-36, 2022.
  16. Fujimori K, Kato Y, Umebayashi Y: Resolution of palmoplantar pustulosis and associated osteoarthritis after colorectal cancer surgery. Int J Dermatol. 2022. Dec 2. doi: 10.1111/ijd.16535. Online ahead of print.
  17. 黒川一郎, 野村有子, 乃木田俊辰: 新規アスコルビン酸誘導体含有化粧品のニキビ患者での効果と期待　外来患者対象の臨床試験結果. 日臨皮医誌 39(5): 676-679, 2022.

皮膚科学分野について

皮膚科診療について

研究・業績